TY - JOUR AU - Fang, Yuting AU - Zhang, Xin AU - Wang, Ji AU - Han, Xinxin PY - 2026 TI - Landscape of liver organoids, liver cancer organoids, and other liver disease organoids JO - Cell Organoid SN - 3007-6552 AB - The liver is the body’s central metabolic organ. Liver organoids have emerged as powerful tools to model it. Three-dimensional organoid systems are expected to reproduce many key liver functions. These functions include detoxification, protein synthesis, and bile production. Liver organoids allow researchers to study liver biology, disease mechanisms, and drug responses in vitro. This review systematically examines liver organoid development. We cover classification, cellular origins, cellular complexity, microenvironment composition, maturation state, translational status, culture methods, and applications. We detail several organoid types. Some derive from embryonic stem cells, induced pluripotent stem cells, or adult stem cells. Others are derived from patients’ tumor tissues and tumor-related samples for liver cancer organoid generation. These include hepatocellular carcinoma organoids, intrahepatic cholangiocarcinoma organoids, and metastatic lesion organoids. We also discuss other disease-specific organoids. These model metabolic dysfunction-associated steatotic liver disease (MASLD), cirrhosis, viral hepatitis, and autoimmune disorders. The review explores key applications. These include basic research, drug discovery, toxicology testing, and regenerative medicine. We also consider future directions, such as bioartificial liver systems. By synthesizing recent advances, this work provides a comprehensive reference. It shows how liver organoids are advancing liver disease research and translational applications. UR - https://doi.org/10.26599/CO.2026.9410026 DO - 10.26599/CO.2026.9410026